Table 3 Use of cardioprotective agents and mortality
Drug class | Total (n = 424) | Mortality (%) | p-value |
|---|---|---|---|
Beta-Blockers | Yes (n = 252) | 126 (50%) | 0.013 |
No (n = 172) | 65 (37.8%) | ||
ACE Inhibitors | Yes (n = 146) | 69 (47.3%) | 0.507 |
No (n = 278) | 122 (43.9%) | ||
Angiotensin Receptor Blockers | Yes (n = 55) | 26 (47.3%) | 0.722 |
No (n = 369) | 165 (44.7%) | ||
Statins | Yes (n = 164) | 75 (45.7%) | 0.822 |
No (n = 260) | 116 (44.6%) |